Abstract:Though the antidiabetic effect of ginsenoside compound K (CK) has been well studied, the effect of CK on diabetic nephropathy (DN) is not clear. Whether CK would have a protective effect against DN and it could exert the protective effect by inhibiting the oxidative stress, NLRP3 inflammasome and NF-κB/p38 signaling pathway were investigated in this study. Here, the HFD (high fat diet)/STZ (streptozotocin)-induced DN mice model was established to assess the CK effect in vivo. Parallel experiments uncovering the molecular mechanism by which CK prevents from DN was performed in rat glomerular mesangial cell line HBZY-1 exposed to high glucose. CK (10, 20, 40 mg/kg/day) were intragastrically administered for 8 weeks, the general status, biochemical parameters, renal pathological changes and oxidative stress-parameters were observed, and the NLRP3 inflammasome and NF-κB/p38 signaling pathway were evaluated. The results showed that the elevated fasting blood glucose, serum creatinine, blood urea nitrogen and 24-hour urine protein of the DN mice were significantly decreased, and the proliferation of glomerular mesangial matrix was alleviated by CK. In addition, the generation of ROS in the kidney was significantly decreased, and the expression of Nox1 and Nox4 proteins were down-regulated. Further, the expression of NLRP3 inflammasome components (NLRP3, ASC and Caspase-1) and the inflammatory cytokines IL-1β and IL-18 were also significantly down-regulated in vivo and in vitro. The phosphorylation of renal p38 MAPK was also inhibited by CK. MCC950 (an inhibitor of NLRP3 inflammasome) and VX-765 (a Caspase-1 Inhibitor) showed significant interaction with CK on the decrease of IL-1β concentration in HBZY-1 cells. In conclusion, our study provided evidence that the protective effect of CK on diabetes-induced renal injury is associated with down-regulating the expression of NADHP oxidase, and inhibition of ROS-mediated activation of NLRP3 inflammasome and NF-κB/p38 signaling pathway, suggesting its therapeutic implication for renal inflammation.

Oral Nf-Kappa B Blockade Attenuates Pro-Inflammatory Cytokines in the Hypothalamic Paraventricular Nucleus of Streptozotocin-Induced Diabetes

Oxidative Stress Mediates Activation of NF‐κB and Contributes to Pathogenesis of Streptozotocin‐induced Diabetes

Pro‐inflammatory Cytokines Increase Neuronal Activity in the Hypothalamic Paraventricular Nucleus and Contribute to the Pathogenesis of Streptozotocin‐induced Diabetes

Insulin-Attenuated Inflammatory Response of Dendritic Cells in Diabetes by Regulating RAGE-PKCβ1-IRS1-NF-κB Signal Pathway: A Study on the Anti-Inflammatory Mechanism of Insulin in Diabetes

Blocking CXC Motif Chemokine Ligand 2 Ameliorates Diabetic Peripheral Neuropathy Via Inhibiting Apoptosis and NLRP3 Inflammasome Activation.

Inhibition of NF-κB ameliorates aberrant retinal glia activation and inflammatory responses in streptozotocin-induced diabetic rats

Tumor Necrosis Factor-Α Blockade Ameliorates Diabetic Nephropathy in Rats.

Inhibition of NF-kappaB Activation by Pyrrolidine Dithiocarbamate Partially Attenuates Hippocampal MMP-9 Activation and Improves Cognitive Deficits in Streptozotocin-Induced Diabetic Rats

PPAR gamma and PGC-1alpha activators protect against diabetic nephropathy by suppressing the inflammation and NF-kappaB activation

Inhibition of Hypothalamic Inhibitor κB Kinase β/Nuclear Transcription Factor κB Pathway Attenuates Metabolism and Cardiac Dysfunction in Type 2 Diabetic Rats

Blockade of P38 Mitogen-Activated Protein Kinase Pathway Ameliorates Delayed Gastric Emptying in Streptozotocin-Induced Diabetic Rats

Inhibition Of Hypothalamic Inhibitor Kappa B Kinase Beta/Nuclear Transcription Factor Kappa B Pathway Attenuates Metabolism And Cardiac Dysfunction In Type 2 Diabetic Rats

CpG-ODN Activation of TLR9 Signaling Pathways and NF-κB in STZ-induced Diabetic Rats

Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress.

Prevention of Diabetes in NOD Mice by Administration of Dendritic Cells Deficient in Nuclear Transcription Factor-Kappab Activity.

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

PPARγ and PGC-1α activators protect against diabetic nephropathy by suppressing the inflammation and NF-κB activation

Inhibition of Hypothalamic Inhibitor B Kinase /Nuclear Transcription Factor B Pathway Attenuates Metabolism and Cardiac Dysfunction in Type 2 Diabetic Rats

Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice

Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease

Prevention of Diabetes in NOD Mice by Administration of Dendritic Cells Deficient in Nuclear Transcription Factor-κB Activity